Cipla informs about company updates

06 Mar 2019 Evaluate

Cipla has informed that the Company and its subsidiary Cipla USA, Inc., announced a phased launch of generic cinacalcet hydrochloride tablets (30mg, 60mg and 90mg) in the USA. The launch is a subject of ongoing litigation.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1331.10 -20.75 (-1.53%)
04-Mar-2026 10:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1742.50
Dr. Reddys Lab 1280.40
Cipla 1331.10
Zydus Lifesciences 896.15
Lupin 2282.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×